| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |